These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28624570)

  • 1. Effects of intrauterine contraception on the vaginal microbiota.
    Bassis CM; Allsworth JE; Wahl HN; Sack DE; Young VB; Bell JD
    Contraception; 2017 Sep; 96(3):189-195. PubMed ID: 28624570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal microbiome changes with levonorgestrel intrauterine system placement.
    Jacobson JC; Turok DK; Dermish AI; Nygaard IE; Settles ML
    Contraception; 2014 Aug; 90(2):130-5. PubMed ID: 24835828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial.
    Kakaire O; Tumwesigye NM; Byamugisha JK; Gemzell-Danielsson K
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):220-6. PubMed ID: 26895345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system.
    Simonatto P; Bahamondes MV; Fernandes A; Silveira C; Bahamondes L
    J Obstet Gynaecol Res; 2016 May; 42(5):554-9. PubMed ID: 26817571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine contraception: incidence and factors associated with uterine perforation--a population-based study.
    Kaislasuo J; Suhonen S; Gissler M; Lähteenmäki P; Heikinheimo O
    Hum Reprod; 2012 Sep; 27(9):2658-63. PubMed ID: 22763376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid-based cervical cytology and microbiological analyses in women using cooper intrauterine device and levonorgestrel-releasing intrauterine system.
    Eleuterio J; Giraldo PC; Silveira Gonçalves AK; Nunes Eleuterio RM
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():20-24. PubMed ID: 33065517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-hormonal and hormonal intrauterine contraception: survey of patients' perceptions in four Latin American countries.
    Silva-Filho AL; Lira J; Rocha AL; Ferreira MC; Lamaita RM; Cândido EB; Carneiro MM
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):213-9. PubMed ID: 26848851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term influence of the levonorgestrel-releasing intrauterine system (Mirena®) on vaginal microbiota and Candida.
    Donders GGG; Bellen G; Ruban K; Van Bulck B
    J Med Microbiol; 2018 Mar; 67(3):308-313. PubMed ID: 29458551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levonorgestrel-releasing intrauterine system is associated with delayed endocervical clearance of Chlamydia trachomatis without alterations in vaginal microbiota.
    Liechty ER; Bergin IL; Bassis CM; Chai D; LeBar W; Young VB; Bell JD
    Pathog Dis; 2015 Nov; 73(8):ftv070. PubMed ID: 26371177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
    Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
    Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in body composition in women using long-acting reversible contraception.
    Silva Dos Santos PN; Madden T; Omvig K; Peipert JF
    Contraception; 2017 Apr; 95(4):382-389. PubMed ID: 28041992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight variation in users of depot-medroxyprogesterone acetate, the levonorgestrel-releasing intrauterine system and a copper intrauterine device for up to ten years of use.
    Modesto W; de Nazaré Silva dos Santos P; Correia VM; Borges L; Bahamondes L
    Eur J Contracept Reprod Health Care; 2015 Feb; 20(1):57-63. PubMed ID: 25160484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of contraceptive initiation on vaginal microbiota.
    Achilles SL; Austin MN; Meyn LA; Mhlanga F; Chirenje ZM; Hillier SL
    Am J Obstet Gynecol; 2018 Jun; 218(6):622.e1-622.e10. PubMed ID: 29505773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of copper-containing and levonorgestrel-releasing intrauterine contraceptives on cervicovaginal cytology and microbiological flora: a prospective study.
    Erol O; Simavlı S; Derbent AU; Ayrım A; Kafalı H
    Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):187-93. PubMed ID: 24738915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of randomization to levonorgestrel versus copper intrauterine device among women requesting IUD insertion for contraception.
    Achilles SL; Chen BA; Lee JK; Gariepy AM; Creinin MD
    Contraception; 2015 Dec; 92(6):572-4. PubMed ID: 26297203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.